Lucifa 40 mg Afatinib Dimaleate is the drug of choice for patients suffering from with certain types of EGFR mutation positive, Non-small cell lung carcinomas that spreading to other parts.
Lucifa 40 mg Afatinib Dimaleate belongs to a type of drugs called kinase inhibitors. These tablets slow down and eventually stop the growth of cancer cells.
Non-small cell lung carcinomas that are metastatic and EGFR positive.
This is not a full list of all side effects that may occur with Lucifa 40 mg Afatinib Dimaleate. Please seek medical advice from your doctor about if you experience serious side effects and drug reactions if they become overtly bothersome.
You must always inform your doctor about your past and present drug allergy, pre-existing medical conditions etc.
Before using Lucifa 40 mg Afatinib Dimaleate, inform your doctor or pharmacist regarding relevant medical history.